Clinic Invent has a number of technologies available in clinical biomedicine at its disposal. Below you will find the latest technology offers with a brief description. For further information and detailed information on the individual technologies and license offers please contact the patent managers of Clinic Invent.
All antibodies are monoclonal unless otherwise specified. For further information and detailed information on the individual antibodies, please contact Dr. Elke Benkhart.
| Antigen | Antibody | Publication |
| mouse VCAM-1 | 6C7 (rat IgG1) | Engelhardt et al. J Clin Invest., 1998, 102(12):2096-2105 |
| mouse Endomucin | V.5C7 (rat IgG1) | Brachtendorf et al. Developmental Dynamics, 2001, 222:410-419; Morgan et al. Blood, 1999, 93(1):165-175 |
| mouse Endomucin | V.1A7 (rat IgG1) | Brachtendorf et al. Developmental Dynamics, 2001, 222:410-419; Morgan et al. Blood, 1999, 93(1):165-175 |
| human 3pK | 3p8-1 (mouse IgG2a, kappa) | not yet published |
| influenza NS1 | NS1.23.1 (mouse) | Ehrhardt et al. Journal of Virology, 2007, 81(21):12097- 12100 |
For further information and detailed information on the individual animal models, please contact Dr. Elke Benkhart.
| Mouse Model | Disease | Publication |
| CREM-lbΔC-X | Atrial fibrillation | Müller et al. Journal of Biological Chemistry, 2005, 280(8):6906-6914; Stümpel et al. Front Pharmacol. 2018 Jul 5;9:706 |
| MBII-85del+/- | Prader-Willi syndrome | Skryabin et al. PLoS Genet., 2007, 3(12):e235:2529-2539 |
| K14-4-1BB TG | Pruritus-like skin disease | Technology Offer |
| TTP-/- x MRP14-/- | Psoriasis | Technology Offer |
